RhoGAM is a brand name for the Rho (D) immunoglobulin. The product has been used in recent years to counteract Rh incompatibility, a relationship between the blood types of a pregnant woman and her fetus. Rh incompatibility occurs when a mother is Rh negative (lacking Rh factor in the blood) and her fetus is Rh positive (containing Rh factor). The mother’s blood perceives the Rh factor in the baby’s blood as a foreign body, and produces antibodies to destroy it. Typically, it takes a number of months for the body to begin producing the antibodies and for them to trace the blood back to the fetus, so the baby may be born in perfect health. However, Rh incompatibility, if unaddressed, can lead to defects or death in future pregnancies.
RhoGAM has been very effective in treating Rh incompatability, but has raised concerns for other reasons. Historically, the product has been produced using a preservative called thimerosal, which contains mercury. Despite Centers for Disease Control arguments to the contrary, many parents and medical experts feel that thimerosal has been responsible for autism and other problems in infants. Thimerosal is currently being phased out of vaccine production, but some units of RhoGAM still contain the preservative.
If you believe that the use of RhoGAM or any vaccine may have led to a debilitating condition in your child, it is important to seek professional legal advice. Regular treatment of autism or any serious medical problem can be expensive and exhausting for all parties involved, and those responsible should help bear the cost. Please contact us today to learn more